MedPath

A clinical trial to study effect of Agnikarma in children with spastic cerebral palsy

Phase 2
Conditions
Health Condition 1: G809- Cerebral palsy, unspecified
Registration Number
CTRI/2024/03/063468
Lead Sponsor
KLE Ayurveda Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

•Children of either sex in age group between 5 years-16 years.

•Children fulfilling the diagnostic criteria.

•Children who have not received any form of modern intervention for spasticity at least for last 1 month.

Exclusion Criteria

•Children with non-spastic Cerebral Palsy will be excluded.

•Children with any known major congenital anomalies like Congenital Heart Disease (CHD) etc. will be excluded.

•Children with other disease status like Acute infections, severe systemic illness and children with any progressive neurologic anomalies will be excluded.

•Children with any other diseases or any other drugs that may interfere with the study outcome will be excluded.

•Children under gone any surgery intervention for spasticity will be excluded.

•Children having local inflammation or skin lesion on the site of spasticity will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ayurveda intervention by Agnikarma is known to reduce spasticity when measured on Modified Tardieu scale and <br/ ><br>Composite spasticity index <br/ ><br>Timepoint: 0th day 7th day <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Ayurveda intervention by Agnikarma is known to reduce spasticity when measured on Range of motion by Universal Goniometry <br/ ><br>Timepoint: 0th day 7th day
© Copyright 2025. All Rights Reserved by MedPath